Update: The story was expanded with a statement from Oura
After staying away from the US market, due to a patent infringement case, Ultrahuman has cleared US Customs and Border Protection and is officially back on sale in the country.
It’s welcome news for US customers, and the Ultrahuman is one of the few smart rings that gives you access to all tracking data without needing to register. The even better news is that if you are one of the first buyers, you can get it at a huge discount.
What makes the Ring PRO worthy of attention?
Let’s start with the battery life. Ring PRO offers up to 15 days on a single charge. Pair it with the new PRO charging case, and jump to 45 days. That is not a mistake. You can last a month and a half without needing a charger.
The ring is made of titanium unibody and uses a dual-core processor with machine learning chip for more accurate health information. It can store up to 250 days of health data directly on the device, so you’re not always tied to your phone.
Other notable features include up to 100 meters (328 feet) of water resistance, find my case, and wireless charging of the case, among others.
If you want more, optional PowerPlugs add medical-grade features like AFib detection, a world-leading smart ring, ovulation tracking with 90% accuracy, snoring analysis, and even GLP-1 medication monitoring.
Do you need to pay a subscription?
No, and that’s the best part. Unlike its competitors, Ultrahuman doesn’t lock basic health tracking behind a monthly paywall. Sleep, recovery, stress, and movement data are all free.
Any special introductory price?
To make the launch even more attractive to consumers, Ultrahuman is offering early bird pricing starting at $349 for the first 1,000 orders, which includes both the Ring PRO and the PRO Charging Case.
That’s $130 off the regular bundle price of $479. The price goes up as the stages fill up, so act fast. You can pre-order tomorrow morning, with the earliest shipping being May 15.
Oura reached out to us and provided the following statement:
‘Since 2013, Oura has led the innovation of the smart ring and protected it with an extensive IP portfolio, proven, through ITC issuance orders, court rulings supporting important patents, and long-term licensing agreements. Our focus remains on providing members with the highest level of accuracy and detail, and on ensuring that this category develops on the basis of originality, clinical rigor, and respect for intellectual property.
The latest CBP decision is not the final or definitive decision on the new Ultrahuman design. It is a narrow, early cultural determination regarding the one right of Oura and the one design of the Ultrahuman ring; does not resolve our extensive patent disputes in the Eastern District of Texas where we have asserted several US patents against Ultrahuman and cited concerns about their credibility and conduct in this dispute. We are reviewing the original decision closely and evaluating next steps, including possible appeals and additional enforcement options where appropriate.’